149 related articles for article (PubMed ID: 31749048)
21. Epidemiology of proliferative diabetic retinopathy.
Klein R; Klein BE; Moss SE
Diabetes Care; 1992 Dec; 15(12):1875-91. PubMed ID: 1464243
[TBL] [Abstract][Full Text] [Related]
22. A 5-year follow-up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators.
Agardh E; Agardh CD; Torffvit O
J Intern Med; 1994 Apr; 235(4):353-8. PubMed ID: 8151268
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study).
Ahola AJ; Saraheimo M; Forsblom C; Hietala K; Sintonen H; Groop PH;
Nephrol Dial Transplant; 2010 Jun; 25(6):1903-8. PubMed ID: 20037167
[TBL] [Abstract][Full Text] [Related]
24. Early photocoagulation in patients with either type I or type II diabetes.
Ferris F
Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus.
Marshall G; Garg SK; Jackson WE; Holmes DL; Chase HP
Ophthalmology; 1993 Aug; 100(8):1133-9. PubMed ID: 8341492
[TBL] [Abstract][Full Text] [Related]
26. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy.
Kofoed-Enevoldsen A; Jensen T; Borch-Johnsen K; Deckert T
J Diabet Complications; 1987; 1(3):96-9. PubMed ID: 2969913
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes.
Laiginhas R; Madeira C; Lopes M; Neves JS; Barbosa M; Rosas V; Carvalho D; Falcão-Reis F; Falcão M
Endocrine; 2019 Nov; 66(2):201-209. PubMed ID: 31407162
[TBL] [Abstract][Full Text] [Related]
28. Physical activity and the risk of progression of retinopathy or the development of proliferative retinopathy.
Cruickshanks KJ; Moss SE; Klein R; Klein BE
Ophthalmology; 1995 Aug; 102(8):1177-82. PubMed ID: 9097744
[TBL] [Abstract][Full Text] [Related]
29. Determinants of retinopathy progression in type 1 diabetes mellitus.
Cohen RA; Hennekens CH; Christen WG; Krolewski A; Nathan DM; Peterson MJ; LaMotte F; Manson JE
Am J Med; 1999 Jul; 107(1):45-51. PubMed ID: 10403352
[TBL] [Abstract][Full Text] [Related]
30. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
[TBL] [Abstract][Full Text] [Related]
31. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
[TBL] [Abstract][Full Text] [Related]
32. Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes.
Manaviat MR; Rashidi M; Afkhami-Ardekani M
Eur J Ophthalmol; 2008; 18(4):572-7. PubMed ID: 18609477
[TBL] [Abstract][Full Text] [Related]
33. Interval between onset of mild nonproliferative and proliferative retinopathy in type I diabetes.
Vitale S; Maguire MG; Murphy RP; Hiner C; Rourke L; Sackett C; Patz A
Arch Ophthalmol; 1997 Feb; 115(2):194-8. PubMed ID: 9046254
[TBL] [Abstract][Full Text] [Related]
34. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with the development of retinopathy 10 yr after the diagnosis of juvenile-onset type 1 diabetes in Taiwan: a cohort study from the CGJDES.
Wang NK; Lai CC; Wang JP; Wu WC; Liu L; Yeh LK; Tseng HJ; Chang CJ; Lo FS;
Pediatr Diabetes; 2016 Sep; 17(6):407-16. PubMed ID: 26332951
[TBL] [Abstract][Full Text] [Related]
36. Impact of overweight on chronic microvascular complications in type 1 diabetic patients.
De Block CE; De Leeuw IH; Van Gaal LF
Diabetes Care; 2005 Jul; 28(7):1649-55. PubMed ID: 15983315
[TBL] [Abstract][Full Text] [Related]
37. Diabetic retinopathy during pregnancy.
Axer-Siegel R; Hod M; Fink-Cohen S; Kramer M; Weinberger D; Schindel B; Yassur Y
Ophthalmology; 1996 Nov; 103(11):1815-9. PubMed ID: 8942876
[TBL] [Abstract][Full Text] [Related]
38. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.
Lövestam-Adrian M; Agardh CD; Torffvit O; Agardh E
Acta Ophthalmol Scand; 2003 Jun; 81(3):221-5. PubMed ID: 12780397
[TBL] [Abstract][Full Text] [Related]
39. Influence of Age at Diagnosis and Time-Dependent Risk Factors on the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes.
Forga L; Goñi MJ; Ibáñez B; Cambra K; García-Mouriz M; Iriarte A
J Diabetes Res; 2016; 2016():9898309. PubMed ID: 27213158
[TBL] [Abstract][Full Text] [Related]
40. Age at onset and the risk of proliferative retinopathy in type 1 diabetes.
Hietala K; Harjutsalo V; Forsblom C; Summanen P; Groop PH;
Diabetes Care; 2010 Jun; 33(6):1315-9. PubMed ID: 20185730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
